Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S).
Saved in:
| Title: | Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S). |
|---|---|
| Authors: | Luvira V; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Lawpoolsri S; Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand., Phumratanaprapin W; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Jongkaewwattana A; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand., Nanthapisal S; Faculty of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, Thailand., Muangnoicharoen S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Kamolratanakul S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Sabmee Y; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Duangdee C; Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Narakorn P; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Surichan S; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Mercer LD; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Raghunandan R; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Polyak CS; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Wirachwong P; The Government Pharmaceutical Organization, 75/1 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand., Flores J; PATH, 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA., Pitisuttithum P; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Electronic address: punnee.pit@mahidol.ac.th. |
| Source: | Vaccine [Vaccine] 2025 Aug 30; Vol. 62, pp. 127601. Date of Electronic Publication: 2025 Aug 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
